Close Menu

In 2006, then-Senator Barack Obama introduced the Genomics and Personalized Medicine Act to the US Congress. Now, the bill is being reintroduced as GPMA 2010 as a response to growing public awareness of genomic tests, according to Genomics Law Report's Dan Vorhaus and Meggan Bushee. The act aims to expand and accelerate genomic research to improve disease diagnosis and to expand the use of personalized medicine, among other things.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.